Ticker League

Operating Margin for Bristol-Myers Squibb (BMY)

As of · Reported

Metric

TTM

25.7%

YoY change

+6.35pp

Trough year (2020)

10.6%

Peak year (2000)

32.9%

Operating Margin history chart for Bristol-Myers Squibb (BMY) from 1987 to 2025

Latest: 26.3%

Operating Margin change chart for Bristol-Myers Squibb (BMY) from 1987 to 2025

Latest: +6.35pp

Operating Margin history table for Bristol-Myers Squibb (BMY) from 1987 to 2025

  • 202526.3%+6.35pp
  • 202420.0%+1.17pp
  • 202318.8%-1.26pp
  • 202220.1%-0.48pp
  • 202120.6%+10.00pp
  • 202010.6%-14.06pp
  • 201924.6%-3.71pp
  • 201828.3%+3.12pp
  • 201725.2%-1.44pp
  • 201626.7%+2.88pp
  • 201523.8%+4.04pp
  • 201419.7%+0.64pp
  • 201319.1%-5.11pp
  • 201224.2%-7.56pp
  • 201131.8%+0.29pp
  • 201031.5%+4.65pp
  • 200926.8%+3.17pp
  • 200823.7%+4.20pp
  • 200719.5%+4.72pp
  • 200614.7%-6.73pp
  • 200521.5%-2.77pp
  • 200424.2%+0.64pp
  • 200323.6%+0.98pp
  • 200222.6%-3.92pp
  • 200126.6%-6.31pp
  • 200032.9%+6.95pp
  • 199925.9%+1.54pp
  • 199824.4%-2.20pp
  • 199726.6%+0.33pp
  • 199626.2%-0.02pp
  • 199526.3%-0.62pp
  • 199426.9%+5.82pp
  • 199321.1%+3.49pp
  • 199217.6%-7.22pp
  • 199124.8%+1.59pp
  • 199023.2%+11.41pp
  • 198911.8%-8.90pp
  • 198820.7%+1.27pp
  • 198719.4%—

Operating Margin values are taken from Bristol-Myers Squibb's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Operating Margin at Bristol-Myers Squibb (BMY)

According to Bristol-Myers Squibb's latest reported financial statements, the company's latest reported operating margin is 25.7%. Operating margin is operating income divided by revenue — the share of each sales dollar left after cost of goods sold and operating expenses (SG&A, R&D), but before interest and taxes. It isolates how profitable the core business is before financing and tax decisions, so it is comparable across companies with different capital structures.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

As of the 2025 fiscal year, Bristol-Myers Squibb (BMY) reported operating margin of 26.34% – expanded 6.3 percentage points year-over-year.

Across the available history, operating margin reached its high of 32.86% in 2000 and its low of 10.56% in 2020.

Bristol-Myers Squibb Operating Margin by Year

Bristol-Myers Squibb Operating Margin 2025: 26.3%

In 2025, Bristol-Myers Squibb reported operating margin of 26.34%, expanded 6.3 percentage points from 2024.

Bristol-Myers Squibb Operating Margin 2024: 20.0%

Bristol-Myers Squibb operating margin in 2024 was 20.00%, expanded 1.2 percentage points from 2023.

Bristol-Myers Squibb Operating Margin 2023: 18.8%

2023's operating margin for Bristol-Myers Squibb came in at 18.82%, contracted 1.3 percentage points from 2022.

Bristol-Myers Squibb Operating Margin 2022: 20.1%

Bristol-Myers Squibb posted operating margin of 20.08% in 2022, contracted 0.5 percentage points from 2021.

Bristol-Myers Squibb Operating Margin 2021: 20.6%

Bristol-Myers Squibb operating margin in 2021 was 20.57%.

See more financial history for Bristol-Myers Squibb (BMY).

Sector peers by Operating Margin

Healthcare peers of Bristol-Myers Squibb (BMY), ranked by their latest operating margin

Frequently asked questions

Bristol-Myers Squibb (BMY) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview